Combination gel of 2% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain - a case report of pain control success

Rev Esp Anestesiol Reanim (Engl Ed). 2021 May;68(5):293-296. doi: 10.1016/j.redare.2020.05.023. Epub 2021 May 5.

Abstract

Erythromelalgia (EM) is a rare autosomal dominant neuropathy characterized by the combination of severe burning pain and erythematous warm extremities. Chronic pain control is most often unsuccessful and a completely effective therapy is yet to be identified. Recent studies have reported significant improvements in pain management using a combination of amitriptyline and ketamine in a topical formulation. We describe a 1-year follow-up pain control success case of a male patient with EM, proposed for topical use of a 2% Amitriptyline and 0.5% Ketamine gel.

Keywords: Amitriptilina; Amitriptyline; Chronic pain; Dolor crónico; Eritromelalgia; Erythromelalgia; Ketamina; Ketamine; Topical; Tópico.

Publication types

  • Case Reports

MeSH terms

  • Amitriptyline / therapeutic use
  • Analgesics / therapeutic use
  • Drug Combinations
  • Erythromelalgia* / drug therapy
  • Humans
  • Ketamine* / therapeutic use
  • Male
  • Pain Management
  • Pain, Intractable*

Substances

  • Analgesics
  • Drug Combinations
  • Amitriptyline
  • Ketamine